未登录

C

Christopher Kitchen

Johns Hopkins Bloomberg School of Public Health

H指数:12

被引数:530

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing the Utility of Social Determinants of Health Data in Suicide Prediction Models

评估健康社会决定因素数据在自杀预测模型中的效用

Archives of Suicide Research

IF2

2026-08-250

PRE

Conceptualization and development of the Maryland suicide data warehouse to improve mortality prediction

马里兰州自杀数据仓库的概念化与开发：以提高死亡率预测为目标

IF3.4

2026-04-230

OA

Use of Vital Records to Improve Identification of Suicide as Manner of Death for Opioid-Related Fatalities

利用生命统计记录提高对阿片类药物相关死亡中自杀死亡性质的识别

CRISIS-THE JOURNAL OF CRISIS INTERVENTION AND SUICIDE PREVENTION

IF2.6

2025-11-011

PRE

Assessing the advantages and disadvantages of dimensionality reduction methods in summarizing housing determinants of health in the United States

评估降维方法在总结美国健康住房决定因素方面的优缺点

IF3.4

2025-08-010

OAAI

Suicide Death Prediction Using the Maryland Suicide Data Warehouse: A Sensitivity Analysis

利用马里兰自杀数据仓库进行自杀死亡预测：一项敏感性分析

Archives of Suicide Research

IF2

2024-06-300

PRE

Prevalence of lifestyle-related behavioral information in claims data in the US

PREVENTIVE MEDICINE

IF3.2

2024-01-010

PRE

Assessing Patient and Community-Level Social Factors; The Synergistic Effect of Social Needs and Social Determinants of Health on Healthcare Utilization at a Multilevel Academic Healthcare System

JOURNAL OF MEDICAL SYSTEMS

IF5.7

2023-09-012

PRE

Evaluating the Use of Online Self-Report Questionnaires as Clinically Valid Mental Health Monitoring Tools in the Clinical Whitespace

PSYCHIATRIC QUARTERLY

IF2.9

2023-05-056

OAAI

Claims-based pharmacy markers for comprehensive medication management program case identification: Validation against concurrent and prospective healthcare costs and utilization

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2022-10-012

PRE

Differential impact of mitigation policies and socioeconomic status on COVID-19 prevalence and social distancing in the United States

BMC PUBLIC HEALTH

IF3.6

2021-06-1430

OAAI

Early relaxation of community mitigation policies and risk of COVID-19 resurgence in the United States

PREVENTIVE MEDICINE

IF3.2

2021-04-019

OAAI

Assessing the association between area deprivation index on COVID-19 prevalence: a contrast between rural and urban U.S. jurisdictions

AIMS PUBLIC HEALTH

IF2.7

2021-01-0122

OAAI

Blinded Clinical Ratings of Social Media Data are Correlated with In -Person Clinical Ratings in Participants Diagnosed with Either Depression, Schizophrenia, or Healthy Controls

PSYCHIATRY RESEARCH

IF3.9

2020-12-016

PREAI

Assessing the Impact of Neighborhood Socioeconomic Characteristics on COVID-19 Prevalence Across Seven States in the United States

FRONTIERS IN PUBLIC HEALTH

IF3.4

2020-09-2261

OAAI

Validation of oxidative stress assay for schizophrenia

精神分裂症氧化应激试验的验证

SCHIZOPHRENIA RESEARCH

IF3.5

2019-10-0117

OAAI

NOVEL TECHNIQUES FOR THERAPEUTIC DRUG MONITORING FOR CLOZAPINE LEVELS

SCHIZOPHRENIA BULLETIN

IF4.8

2019-04-090

OAAI

USING APPROPRIATE OUTCOMES WHEN EVALUATING COGNITIVE BEHAVIOR THERAPY FOR PSYCHOSIS (CBTP) FOR PATIENTS WITH SCHIZOPHRENIA IN AN INPATIENT SETTING: TRENDS OBSERVED IN CLINICAL PRACTICE

SCHIZOPHRENIA BULLETIN

IF4.8

2019-04-090

OAAI

Reliable clinical serum analysis with reusable electrochemical sensor: Toward point-of-care measurement of the antipsychotic medication clozapine

BIOSENSORS & BIOELECTRONICS

IF10.5

2017-09-0137

OAAI

Redox Probing for Chemical Information of Oxidative Stress

ANALYTICAL CHEMISTRY

IF6.7

2017-01-1249

OAAI